Top Markets
#1 Ontology Gas Ontology Gas +31.11%
#2 Verus Coin Verus Coin +22.50%
#3 Status Status +21.81%
#4 Bitway Bitway +15.86%
#5 Geodnet Geodnet +14.90%
#6 ETHGas ETHGas +13.90%
#7 The Black Bull The Black Bull +11.57%
#8 Fake World Assets Fake World Assets +10.89%
#9 Curve DAO Curve DAO +10.88%
#10 Pons Pons +10.78%
Coin of the day
Ontology Gas Ontology Gas
설정
언어
한국어
통화
USD
테마
AlloVir, Inc. AlloVir, Inc.

AlloVir, Inc.

ALVR
주식 순위 #25521
AlloVir, Inc. is a biotechnology company in the clinical stage, dedicated to... AlloVir, Inc. is a biotechnology company in the clinical stage, dedicated to researching and developing allogeneic, "off-the-shelf" multi-virus specific T-cell (VST) therapies. Its primary goal is to prevent and treat severe diseases caused by viral infections. The company's lead product, posoleucel, is an allogeneic, ready-to-use VST therapy designed to combat several significant viruses, including BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, human herpesvirus 6, and JC virus. Beyond this flagship candidate, AlloVir's pipeline features additional investigational treatments in various stages of development. These include ALVR106, which targets respiratory syncytial virus, influenza, parainfluenza virus, and human metapneumovirus; ALVR109, developed to address SARS-CoV-2 and COVID-19; ALVR107, for treating hepatitis B; and ALVR108. Established in 2013, the company was initially known as ViraCyte, Inc. before officially rebranding as AlloVir, Inc. in May 2019. Its headquarters are located in Waltham, Massachusetts.
주가
$9.81
마지막 동기화: 2025-03-18
시가총액
$48.68M
변동 (1일)
1.55%
변동 (1년)
0.00%
국가
US
거래 AlloVir, Inc. (ALVR)

카테고리

Healthcare
AlloVir, Inc. (ALVR)의 매출
Jun 2026 기준 매출 TTM: 0.00
AlloVir, Inc.의 최신 재무 보고서에 따르면 회사의 현재 수익 (TTM)은 0.00입니다. 2023년에 회사는 0.00의 수익을 올렸으며 이는 2022년의 0.00 대비 동일입니다. 수익은 상품이나 서비스를 판매하여 얻은 총 수입을 의미합니다. 수익과는 달리 비용이 차감되지 않습니다.
AlloVir, Inc.의 수익 기록 (2018 ~ 2026)
매년 말 매출
연도 매출 변화
2026 (TTM) 0.00 0.00%
2024 0.00 0.00%
2023 0.00 0.00%
2022 0.00 0.00%
2021 0.00 0.00%
2020 0.00 -100.00%
2019 $165.00K -85.46%
2018 $1.14M 0.00%
유사 기업 또는 경쟁사의 매출
회사 매출 매출 차이 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US